Skip to content

EFFECTIVENESS OF ADJUNCTIVE TRANSCRANIAL ALTERNATING CURRENT STIMULATION IN PATIENTS WITH SCHIZOPHRENIA FOR AUDITORY HALLUCINATION

EFFICACY OF ADJUNCTIVE 40 HZ GAMMA TRANSCRANIAL ALTERNATING CURRENT STIMULATION (TACS) FOR AUDITORY HALLUCINATION IN SCHIZOPHRENIA: A SHAM-CONTROLLED STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055544
Enrollment
40
Registered
2023-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F20- Schizophrenia

Interventions

Intervention1: transcranial alternating current stimulation (tACS), Active: The anode will be placed with the middle of the electrode over a point midway between F3 and FP1 (left DLPFC) and the cathod

Sponsors

Central Institute of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of schizophrenia using diagnostic criteria for research (DCR) of ICDâ??10 DCR (World Health Organization, 1993). 2. PSYRATS auditory hallucination subscale score on item frequency and duration >=2 each. 3. Right-handed. 4. Patients giving written informed consent.

Exclusion criteria

Exclusion criteria: 1. Co-morbid neurological or any other psychiatric disorder. 2. History of substance abuse (except nicotine and caffeine). 3. History of epilepsy, significant head injury or any neurosurgical procedure. 4. Patients who have received electroconvulsive therapy in the past one month.

Design outcomes

Primary

MeasureTime frame
Reduction in scores of auditory hallucinations as recorded by Psychotic Symptom Rating Scale (PSYRATS) - Auditory Hallucination Sub-Scale, and Auditory hallucinations rating scale (AHRS)Timepoint: At completion of tACS sessions i.e., 1 week and at 5 weeks after the initiation of treatment

Secondary

MeasureTime frame
Change in EEG gamma band (30-100 Hz) spectral power and synchronization from baseline to post-treatmentTimepoint: At completion of tACS sessions i.e., 1 week and at 5 weeks after the initiation of treatment

Countries

India

Contacts

Public ContactDr Umesh S

Central Institute of Psychiatry

umesh.yes@hotmail.com9771702403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026